Intel Corporation INTC Among Most Traded US Stocks in 2026 as Analyst Lifts Price Target and McLaren Partnership Unfolds Waymo Halts Robotaxi Operations in Five US Cities After Flooding Incidents Safety Pause Extended Out of Abundance of Caution Trump Postpones AI Executive Order Signing Citing Concerns Over Potential Constraints Dow Jones Futures Edge Higher as SP 500 and Nasdaq Reach New Peaks AI Stocks in Focus Genpact CEO Says AI Could Reduce IT Workload and Jobs Requiring Higher Skill Sets Brent Crude 100 Forecast May Understate Tighter Oil Market Risks Analysts Suggest LOCO Q1 2026 Earnings Strong EPS Beat Highlights Operational Resilience in Challenging Environment BRTX Q1 2026 Earnings Narrowed Loss Surprises Shares Climb 78 CNS Q1 2026 Earnings EPS Misses Estimates by 34 Stock Declines StandardAero Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Kyntra Bio Inc KYNB Q1 2026 Earnings WiderthanExpected Loss Amid PreRevenue RD Push AMR Q1 2026 Earnings Significant EPS Miss Sends Shares Higher on Unusual Reaction Central Securities Corporation CET Edges Higher Approaching Resistance in a Steady Advance Optex Systems Holdings OPXS Advances 2 as Stock Tests Resistance Near 1222 Cypherpunk Technologies CYPH Drops 776 Support Levels Under Scrutiny Basel Medical Group Ltd BMGL Holds Steady at 058 Consolidation Signals Potential Breakout Thayer Ventures Acquisition Corp II TVAI Holds Steady at 1029 as Market Awaits Catalyst Texas Instruments TXN Draws Analyst Scrutiny Amid Semiconductor Cycle Shifts AAR Corp AIR Q1 2026 Earnings Strong EPS Beat Driven by Aftermarket Demand and Operational Discipline MKS Inc MKSI Edges Lower as Stock Navigates Between Key Support and Resistance Levels Pixelworks Q1 2026 Earnings Massive EPS Beat Overshadows Missing Revenue Details BIRD Q1 2026 Earnings EPS Misses Estimates as Losses Widen Ashland Inc ASH Q1 2026 Earnings Narrow EPS Miss Masks Underlying Resilience Shares Rally BVN Q4 2025 Earnings Strong EPS Surprise Driven by Operational Gains CORT Q1 2026 Earnings Sharp EPS Miss Reflects Higher Costs and Absence of Revenue Eikon Therapeutics Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline IRIX Q1 2026 Earnings EPS Surprises to the Upside Despite Limited Revenue Disclosure